Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain
- PMID: 1722593
- DOI: 10.1002/syn.890090405
Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain
Abstract
Central serotonin (5-HT) axons were visualized by immunocytochemistry to assess both acute and long-lasting changes in innervation density following methamphetamine administration to rats. Two morphologically distinct subtypes of 5-HT axons (fine and beaded) were differentially affected by d-methamphetamine (d-MA); the density of fine serotonergic axons was selectively decreased both 4 hours and 2 weeks after administration of d-MA. Acute depletion of 5-HT from fine axons, but not from beaded axons, was observed in the brains of all rats treated 4 hours previously with either a 100 mg/kg or 15 mg/kg dose of d-MA. Persistent loss of 5-HT axons was observed in 30% of rats treated 1 or 2 weeks previously with doses of d-MA which produce long-term deficits in biochemical markers for 5-HT. In the fraction of animals that exhibited denervation, fine serotonergic fibers were selectively ablated by d-MA, but beaded serotonergic fibers were spared. Thus, d-MA is similar to other amphetamine derivatives (e.g., p-chloroamphetamine, 3,4-methylenedioxyamphetamine) in that it acts selectively upon a morphologically distinct class of 5-HT axons but differs in that it produces long-lasting axon loss in only a fraction of animals. These data provide morphologic evidence of 5-HT axon loss following methamphetamine administration and further confirm the differential vulnerability of a particular morphological subtype of serotonergic axons to the neurotoxic effects of substituted amphetamines.
Similar articles
-
Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.J Comp Neurol. 1991 Dec 15;314(3):558-86. doi: 10.1002/cne.903140312. J Comp Neurol. 1991. PMID: 1814975
-
Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain.Synapse. 1993 Nov;15(3):198-208. doi: 10.1002/syn.890150305. Synapse. 1993. PMID: 8278897
-
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.J Neurosci. 1988 Aug;8(8):2788-803. doi: 10.1523/JNEUROSCI.08-08-02788.1988. J Neurosci. 1988. PMID: 2457659 Free PMC article.
-
Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.NIDA Res Monogr. 1997;173:146-74. NIDA Res Monogr. 1997. PMID: 9260188 Review.
-
Neurotoxicity of MDMA and related compounds: anatomic studies.Ann N Y Acad Sci. 1990;600:649-61; discussion 661-4. doi: 10.1111/j.1749-6632.1990.tb16916.x. Ann N Y Acad Sci. 1990. PMID: 1979216 Review.
Cited by
-
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.Drug Alcohol Depend. 2012 Nov 1;126(1-2):87-94. doi: 10.1016/j.drugalcdep.2012.04.020. Epub 2012 May 28. Drug Alcohol Depend. 2012. PMID: 22647900 Free PMC article.
-
Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates.Biol Psychiatry. 2009 Jul 15;66(2):118-27. doi: 10.1016/j.biopsych.2009.02.021. Epub 2009 Apr 5. Biol Psychiatry. 2009. PMID: 19345341 Free PMC article. Review.
-
Effect of amphetamine on the expression of the metabotropic glutamate receptor 5 mRNA in developing rat brain.J Mol Neurosci. 2000 Dec;15(3):177-88. doi: 10.1385/JMN:15:3:177. J Mol Neurosci. 2000. PMID: 11303782
-
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.Drug Target Insights. 2006;1:19-28. Epub 2006 Nov 9. Drug Target Insights. 2006. PMID: 21901055 Free PMC article.
-
Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice.Ann N Y Acad Sci. 2006 Aug;1074:135-48. doi: 10.1196/annals.1369.013. Ann N Y Acad Sci. 2006. PMID: 17105911 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical